http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8425581-B2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a06d6903a768fbdf77b76d92689baec3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc4b9bac000edd370e69a724d19d4fba http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e1b680c98435bdbb0247481b1dee9321 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b48cf941a3e27edadf454f867ee17a39 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2007-126 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F7-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F7-123 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F7-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F7-00 |
| filingDate | 2010-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3d52f46127dc9346682c9d63d2ce7899 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e349a27ffcb8660a2cec83402226a36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35e7087dd105ff77c3b87da578c38d65 |
| publicationDate | 2013-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | US-8425581-B2 |
| titleOfInvention | Inhibition of platelet activation, aggregation and/or adhesion by hypothermia |
| abstract | A method for treating acute coronary syndromes (i.e., unstable angina or non-Q-wave MI) or transient ischemic attacks in a human or animal patient by placing a heat exchange apparatus in the patient=s vasculature and using that heat exchange apparatus to cool the patient to a temperature (e.g. 30-36_C) at which platelet inhibition (i.e., inhibition of platelet activation and/or aggregation and/or adhesion) occurs. Anti-shivering drugs or anesthesia may be administered to patients whose body temperature is cooled below that patient=s shivering threshold (typically approximately 35.5 C). If it is determined that platelet inhibition is no longer desirable, such as when the patient is about to undergo a surgical or interventional procedure wherein bleeding could be problematic, the hypothermia-induced platelet inhibition may be rapidly reversed by using the intravascular heat exchange apparatus to re-warm the patient=s body to normothermia or near normothermia. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10369044-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2013304166-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9358153-B2 |
| priorityDate | 2001-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 94.